Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Finjozy

Generic name: Sertraline hydrochloride

FDA application holder: Ascent Pharms Inc

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Finjozy?
Finjozy is a brand name of Sertraline hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Finjozy product in 1 strength and form.
Who makes Finjozy?
Ascent Pharms Inc holds the FDA application for Finjozy (ANDA214790, approved May 3, 2021).
Is there a generic or store brand of Finjozy?
Other products of Sertraline hydrochloride are listed with the FDA, but none in exactly the same strength and form as a Finjozy product.
Has Finjozy been recalled?
No recall linked to Finjozy products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Finjozy is

Each Finjozy product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Sertraline hydrochloride · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
sertraline hydrochloride 75 mg
tablet (oral)
Finjozy None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sertraline hydrochloride →

FDA approval

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
FDA applications of Finjozy products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
ANDA214790Ascent Pharms IncMay 3, 20211

Companies that list Finjozy

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Finjozy products.

Recalls

No recall linked to Finjozy products (by their NDC code or label) appears in the FDA enforcement reports.

Next steps

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 11, 2026, retrieved November 14, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers